390 related articles for article (PubMed ID: 19213606)
1. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E
Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
[TBL] [Abstract][Full Text] [Related]
2. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
Xue J; Waterman F; Handler J; Gressen E
Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy.
Bowes D; Crook JM; Araujo C; Batchelar D
Brachytherapy; 2013; 12(1):38-43. PubMed ID: 22727473
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Stone NN; Hong S; Lo YC; Howard V; Stock RG
Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
[TBL] [Abstract][Full Text] [Related]
5. Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants.
Haworth A; Ebert M; St Clair S; Carey BM; Flynn A; Bottomley DM; Duchesne GM; Joseph D; Ash D
Brachytherapy; 2005; 4(2):146-53. PubMed ID: 15893269
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the feasibility of using transrectal ultrasound for postimplant dosimetry in low-dose-rate prostate brachytherapy.
Davies RS; Perrett T; Powell J; Barber J; Tanguay J; Button M; Cochlin D; Smith C; Lester JF
Med Dosim; 2016 Winter; 41(4):290-295. PubMed ID: 27623391
[TBL] [Abstract][Full Text] [Related]
7. Prostate brachytherapy intraoperative dosimetry using a combination of radiographic seed localization with a C-arm and deformed ultrasound prostate contours.
Golshan M; Mahdavi SS; Samei G; Lobo J; Pickles T; James Morris W; Keyes M; Peacock M; Salcudean SE; Spadinger I
Brachytherapy; 2020; 19(5):589-598. PubMed ID: 32682777
[TBL] [Abstract][Full Text] [Related]
8. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
[TBL] [Abstract][Full Text] [Related]
9. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
[TBL] [Abstract][Full Text] [Related]
10. The applicability of simultaneous TRUS-CT imaging for the evaluation of prostate seed implants.
Steggerda M; Schneider C; van Herk M; Zijp L; Moonen L; van der Poel H
Med Phys; 2005 Jul; 32(7):2262-70. PubMed ID: 16121581
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative Registered Ultrasound and Fluoroscopy (iRUF) for dose calculation during prostate brachytherapy: Improved accuracy compared to standard ultrasound-based dosimetry.
Lee J; Mian OY; Le Y; Bae HJ; Burdette EC; DeWeese TL; Prince JL; Song DY
Radiother Oncol; 2017 Jul; 124(1):61-67. PubMed ID: 28647400
[TBL] [Abstract][Full Text] [Related]
12. Localization of linked 125I seeds in postimplant TRUS images for prostate brachytherapy dosimetry.
Xue J; Waterman F; Handler J; Gressen E
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):912-9. PubMed ID: 15936577
[TBL] [Abstract][Full Text] [Related]
13. Comparison between postoperative TRUS-CT fusion with MRI-CT fusion for postimplant quality assurance in prostate LDR permanent seed brachytherapy.
Tisseverasinghe S; Marbán M; Crook J; Petrik D; Araujo C
Brachytherapy; 2021; 20(4):849-856. PubMed ID: 33867295
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of post-plan dosimetry using TRUS and CT after transperineal prostate seed implant.
Helmick R; Tarver R; Chan R; Caldwell S
Med Dosim; 2002; 27(4):289-93. PubMed ID: 12521076
[TBL] [Abstract][Full Text] [Related]
15. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
[TBL] [Abstract][Full Text] [Related]
16. Prostate volume measurement by transrectal ultrasound and computed tomography before and after permanent prostate brachytherapy.
Solhjem MC; Davis BJ; Pisansky TM; Wilson TM; Mynderse LA; Herman MG; King BF; Geyer SM
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):767-76. PubMed ID: 15465193
[TBL] [Abstract][Full Text] [Related]
17. MRI-based preplanning in low-dose-rate prostate brachytherapy.
Tanaka O; Hayashi S; Matsuo M; Nakano M; Kubota Y; Maeda S; Ohtakara K; Deguchi T; Hoshi H
Radiother Oncol; 2008 Jul; 88(1):115-20. PubMed ID: 17933407
[TBL] [Abstract][Full Text] [Related]
18. Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images.
Ohashi T; Momma T; Yamashita S; Nagatsuma K; Kanai K; Kitagawa K; Takahashi S; Hanada T; Yorozu A; Shigematsu N
Brachytherapy; 2012; 11(6):468-75. PubMed ID: 22330102
[TBL] [Abstract][Full Text] [Related]
19. Computing intraoperative dosimetry for prostate brachytherapy using TRUS and fluoroscopy.
French D; Morris J; Keyes M; Goksel O; Salcudean S
Acad Radiol; 2005 Oct; 12(10):1262-72. PubMed ID: 16179203
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]